These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36574521)

  • 1. Integrated Multi-Omics Landscape of Liver Metastases.
    Yang S; Qian L; Li Z; Li Y; Bai J; Zheng B; Chen K; Qiu X; Cai G; Wang S; Huang H; Wu J; Zhu Y; Zhangyang Q; Feng L; Wu T; Wu R; Yang A; Wang K; Wang R; Zhang Y; Zhao Y; Wang W; Bao J; Shen S; Hu J; Wu X; Zhou T; Meng Z; Liu W; Wang H; Wang P; Chen L
    Gastroenterology; 2023 Mar; 164(3):407-423.e17. PubMed ID: 36574521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
    Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers.
    Liu X; Xu X; Wu Z; Shan Q; Wang Z; Wu Z; Ding X; Huang W; Wang Z
    Front Immunol; 2022; 13():961350. PubMed ID: 36172359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
    Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
    J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTSB
    Lin C; Yang H; Zhao W; Wang W
    Biochem Biophys Res Commun; 2022 Oct; 626():8-14. PubMed ID: 35964553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma.
    Sun Y; Wu P; Zhang Z; Wang Z; Zhou K; Song M; Ji Y; Zang F; Lou L; Rao K; Wang P; Gu Y; Gu J; Lu B; Chen L; Pan X; Zhao X; Peng L; Liu D; Chen X; Wu K; Lin P; Wu L; Su Y; Du M; Hou Y; Yang X; Qiu S; Shi Y; Sun H; Zhou J; Huang X; Peng DH; Zhang L; Fan J
    Cancer Cell; 2024 Jan; 42(1):135-156.e17. PubMed ID: 38101410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.
    Yang B; Li X; Zhang W; Fan J; Zhou Y; Li W; Yin J; Yang X; Guo E; Li X; Fu Y; Liu S; Hu D; Qin X; Dou Y; Xiao R; Lu F; Wang Z; Qin T; Wang W; Zhang Q; Li S; Ma D; Mills GB; Chen G; Sun C
    Cell Rep Med; 2022 Dec; 3(12):100856. PubMed ID: 36543113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
    Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
    Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors.
    Gui M; Huang S; Li S; Chen Y; Cheng F; Liu Y; Wang JA; Wang Y; Guo R; Lu Y; Cao P; Zhou G
    J Transl Med; 2024 Feb; 22(1):206. PubMed ID: 38414027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.
    Zhou G; Noordam L; Sprengers D; Doukas M; Boor PPC; van Beek AA; Erkens R; Mancham S; Grünhagen D; Menon AG; Lange JF; Burger PJWA; Brandt A; Galjart B; Verhoef C; Kwekkeboom J; Bruno MJ
    Oncoimmunology; 2018; 7(7):e1448332. PubMed ID: 29900067
    [No Abstract]   [Full Text] [Related]  

  • 12. The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype.
    Linxweiler M; Kuo F; Katabi N; Lee M; Nadeem Z; Dalin MG; Makarov V; Chowell D; Dogan S; Ganly I; Hakimi AA; Wong RJ; Riaz N; Ho AL; Chan TA; Morris LGT
    Clin Cancer Res; 2020 Jun; 26(12):2859-2870. PubMed ID: 32060100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer.
    Zou Y; Ye F; Kong Y; Hu X; Deng X; Xie J; Song C; Ou X; Wu S; Wu L; Xie Y; Tian W; Tang Y; Wong CW; Chen ZS; Xie X; Tang H
    Adv Sci (Weinh); 2023 Feb; 10(5):e2203699. PubMed ID: 36529697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective.
    Ortiz MMO; Andrechek ER
    J Mammary Gland Biol Neoplasia; 2023 Jun; 28(1):12. PubMed ID: 37269418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases.
    Brunsell TH; Sveen A; Bjørnbeth BA; Røsok BI; Danielsen SA; Brudvik KW; Berg KCG; Johannessen B; Cengija V; Abildgaard A; Guren MG; Nesbakken A; Lothe RA
    Clin Colorectal Cancer; 2020 Mar; 19(1):e26-e47. PubMed ID: 31982351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated multi-omics characterization of KRAS mutant colorectal cancer.
    Chong W; Zhu X; Ren H; Ye C; Xu K; Wang Z; Jia S; Shang L; Li L; Chen H
    Theranostics; 2022; 12(11):5138-5154. PubMed ID: 35836817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
    Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
    Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGP promotes CD8
    Rong D; Sun G; Zheng Z; Liu L; Chen X; Wu F; Gu Y; Dai Y; Zhong W; Hao X; Zhang C; Pan X; Tang J; Tang W; Wang X
    Int J Biol Sci; 2022; 18(6):2345-2361. PubMed ID: 35414780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.